Namwiwat Medical Corporation PCL (BKK:NAM)
Thailand · Delayed Price · Currency is THB 3.720
-0.060 (-1.59%)
At close: Mar 27, 2026
BKK:NAM Cash Flow Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 101.59 | 180.87 | 200.75 | 175.71 | 174.65 |
Depreciation & Amortization | 62.95 | 30.57 | 28.61 | 20.41 | 17.67 |
Other Amortization | 8.78 | 7.25 | 1.02 | 0.9 | 0.41 |
Loss (Gain) From Sale of Assets | -0.19 | 0.14 | -10.28 | -5.44 | -1.22 |
Asset Writedown & Restructuring Costs | 1.7 | - | -1.23 | 2.35 | 0.42 |
Loss (Gain) From Sale of Investments | -0.8 | -1.96 | -2.16 | -0.59 | - |
Loss (Gain) on Equity Investments | - | - | - | 0.55 | 0.27 |
Provision & Write-off of Bad Debts | 0.73 | 5.85 | -7.09 | -6.56 | 10.78 |
Other Operating Activities | -1.31 | 13.62 | 10.67 | -3.92 | 24.3 |
Change in Accounts Receivable | 238.68 | -242.45 | 52.85 | -194.59 | -11.15 |
Change in Inventory | -212.66 | -80.69 | 17.12 | 27.96 | -203.31 |
Change in Accounts Payable | -108 | 75.39 | -54.37 | 25.53 | 53.17 |
Change in Unearned Revenue | -0.62 | 0.63 | -14.62 | 0.64 | 6.18 |
Change in Other Net Operating Assets | -53 | 33.73 | 37.43 | -124.13 | 21.45 |
Operating Cash Flow | 37.86 | 22.94 | 258.68 | -81.16 | 93.61 |
Operating Cash Flow Growth | 65.06% | -91.13% | - | - | -10.60% |
Capital Expenditures | -42.79 | -55.57 | -30.41 | - | - |
Sale of Property, Plant & Equipment | 0.27 | 0.41 | 1.12 | - | - |
Cash Acquisitions | -107.03 | -33.05 | - | - | - |
Sale (Purchase) of Intangibles | -25.88 | -22.87 | -8.42 | -53.6 | -0.97 |
Sale (Purchase) of Real Estate | - | - | - | -38.44 | -31.33 |
Investment in Securities | 59.78 | 44.93 | 200 | -300 | - |
Other Investing Activities | 24.92 | -7.86 | - | - | - |
Investing Cash Flow | -90.74 | -74.01 | 162.28 | -392.04 | -32.3 |
Short-Term Debt Issued | - | 3.89 | - | - | 5 |
Long-Term Debt Issued | 284.88 | 122.5 | - | - | 24 |
Total Debt Issued | 284.88 | 126.39 | - | - | 29 |
Short-Term Debt Repaid | - | - | - | -67.62 | -34.88 |
Long-Term Debt Repaid | -268.02 | -99.15 | -36.35 | -37.69 | -43.05 |
Total Debt Repaid | -268.02 | -99.15 | -36.35 | -105.31 | -77.93 |
Net Debt Issued (Repaid) | 16.86 | 27.24 | -36.35 | -105.31 | -48.93 |
Issuance of Common Stock | - | - | 784.08 | 839.39 | - |
Common Dividends Paid | -175 | -62.99 | -232.05 | -242.5 | - |
Other Financing Activities | -12 | 12 | 0 | - | - |
Financing Cash Flow | -170.14 | -23.74 | 515.67 | 491.58 | -48.93 |
Net Cash Flow | -223.02 | -74.82 | 936.64 | 18.38 | 12.38 |
Free Cash Flow | -4.94 | -32.64 | 228.27 | -81.16 | 93.61 |
Free Cash Flow Growth | - | - | - | - | -10.60% |
Free Cash Flow Margin | -0.26% | -2.93% | 20.74% | -7.38% | 9.40% |
Free Cash Flow Per Share | -0.01 | -0.05 | 0.37 | -3.09 | 4.68 |
Cash Interest Paid | 25.42 | 12.92 | 14.05 | 13.45 | 11.2 |
Cash Income Tax Paid | 58.69 | 39.35 | 50.71 | 54.5 | 29.14 |
Levered Free Cash Flow | -155.34 | -162.68 | 180.92 | -173.57 | 38.41 |
Unlevered Free Cash Flow | -140.75 | -154.76 | 190.75 | -165.46 | 47.19 |
Change in Working Capital | -135.59 | -213.39 | 38.4 | -264.59 | -133.67 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.